Serious QT interval prolongation with ranolazine and amiodarone

International Journal of Cardiology

Volumn 172, Issue 1, 2014, Pages

  Tarapués, Mónica ^a   Cereza, Gloria ^a,c,d   Arellano, Ana Lucía ^b   Montané, Eva ^a,b   Figueras, Albert ^a,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c Institut Catala de Farmacologia   (Spain)

^d Catalan Centre of Pharmacovigilance   (Spain)

Author keywords

Adverse drug reaction; Amiodarone; Angina; QT interval prolongation; Ranolazine

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ALLOPURINOL; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FUROSEMIDE; GLICLAZIDE; GLYCERYL TRINITRATE; HYDRALAZINE; OMEPRAZOLE; RANOLAZINE; SIMVASTATIN; TOPIRAMATE; ACETANILIDE DERIVATIVE; PIPERAZINE DERIVATIVE; SODIUM CHANNEL BLOCKING AGENT;

ACUTE HEART FAILURE; AGED; ANGINA PECTORIS; BREATHING DISORDER; CASE REPORT; DEFIBRILLATION; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART VENTRICLE BIGEMINY; HEART VENTRICLE EXTRASYSTOLE; HUMAN; LETTER; LOW DRUG DOSE; MITRAL VALVE REGURGITATION; ORTHOPNEA; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; TORSADE DES POINTES; CHEMICALLY INDUCED; ELECTROCARDIOGRAPHY; LONG QT SYNDROME; TORSADES DE POINTES;

ACETANILIDES; AGED; AMIODARONE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; PIPERAZINES; SODIUM CHANNEL BLOCKERS; TORSADES DE POINTES;

EID: 84894030366     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.061     Document Type: Article

References (11)

1. D.M. Roden Drug-induced prolongation of the QT interval N Engl J Med 350 2004 1013 1022
2. A.J. Camm Safety considerations in the pharmacological management of atrial fibrillation Int J Cardiol 127 3 2008 299 306
3. S.H. Hohnloser, T. Klingenheben, and B.N. Singh Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia Ann Intern Med 121 1994 529 535
4. P. Foley, P. Kalra, and N. Andrews Amiodarone - avoid the danger of torsade de pointes Resuscitation 76 2008 137 141
5. S.P. Kounas, K.P. Letsas, A. Sideris, M. Efraimidis, and F. Kardaras QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone Pacing Clin Electrophysiol 28 5 2005 472 473
6. Ranexa ® EPAR Product information. EMA http://www.ema.europa.eu/ema/ index.jsp?curl=pages/medicines/human/medicines/000805/human-med-001009. jsp&mid=WC0b01ac058001d124 [Accessed 25Sept 2013]
7. M. Jerling Clinical pharmacokinetics of ranolazine. Clinical pharmacokinetics of ranolazine Clin Pharmacokinet 45 2006 469 491
8. D.A. Morrow, B.M. Scirica, and E. Karwatowska-Prokopczuk et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA 297 2007 1775 1783
9. D.A. Pierce, and A.M. Reeves-Daniel Ranolazine-tacrolimus interaction Ann Pharmacother 44 2010 1844 1849
10. N. Fragakis, K.C. Koskinas, D.G. Katritsis, E.D. Pagourelias, T. Zografos, and P. Geleris Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset a trial fibrillation Am J Cardiol 110 2012 673 677
11. ClinicalTrials.gov Safety of Amiodarone and Ranolazine Together in Patients with Angina (SARA) Available: http://clinicaltrials.gov/show/ NCT01558830 [Accessed 27 June 2013]